Evidence map›Paper›PMID 23423416›Full record

SynthesisJAMA2013

Insomnia.

Daniel J Buysse

3 registry-linked trialsOpen access · greenAbstract readCase ReportsClinical ConferenceSystematic Review
In one paragraph

Synthesis in JAMA, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 443 papers, 16 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
443citing papers in PubMed, 16 pooled it
43.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02535923 nacompletednot on this mapstarted 2018, after this paper: background citation

CBT-I for Psychosis: Guidelines, Preliminary Efficacy, and Functional Outcomes

TypeinterventionalSponsorVA Office of Research and DevelopmentRan2018 to 2021Enrolled47ConditionsInsomnia, PsychosisArmsCognitive Behavioral Therapy-Insomnia, Health and Wellness
NCT03267537 naunknown statusnot on this mapstarted 2017, after this paper: background citation

Non-inferiority Study of Telemedicine Versus Conventional CBT-I in Recently Hospitalized Patients With Insomnia

TypeinterventionalSponsorUniversity of ArizonaRan2017 to 2019Enrolled74ConditionsInsomniaArmsTelemedicine CBT-I, Conventional office-based CBT-I
NCT06606938 nanot yet recruitingnot on this mapstarted 2024, after this paper: background citation

Faecal Microbiota Transplantation for Insomnia Disorder: a Randomized, Double-blind, Placebo-controlled Trial

TypeinterventionalSponsorChinese University of Hong KongRan2024 to 2027Enrolled74ConditionsChronic Insomnia DisorderArmsFaecal Microbiota Transplantation, Normal Saline (Placebo)
3 · Its place in the literature

Who cites it

443 citing papers in PubMed, 16 syntheses or guidelines pooled it, 922 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Results of a pilot randomized controlled trial of CBT-I for veterans with serious mental illness and insomnia.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2026
    Trial
  18. Trial
  19. Trial
  20. Trial

383 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Daniel J BuysseNeuroscience Clinical and Translational Research Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. buyssedj@upmc.edu
University of Pittsburgh · US

Funding

UNIVERSITY OF PITTSBURGH CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE: BPCAUL1RR024153 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2006 to 2011
$73.9M
University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
REDUCING STRESS /SLEEP DISTURBANCES IN CAREGIVERS OF ADP01AG020677 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BUYSSE, DANIEL J. · 2003 to 2015
$17.5M
Validation and domain development in mental health and sleep-wake functionU01AR052155 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PILKONIS, PAUL A · 2004 to 2013
$6.0M
Testing a Neurobiological Model of Primary InsomniaR01MH024652 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BUYSSE, DANIEL J. · 1985 to 2011
$5.1M
2/3-Improving Depression Outcome by Adding CBT for Insomnia to AntidepressantsR01MH078961 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BUYSSE, DANIEL J. · 2008 to 2012
$1.3M
Security and Vigilance in Military Couples: A Dynamic Model of Sleep, InterpersonR01HL112646 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TROXEL, WENDY M · 2011 to 2014
$1.3M
Behavioral and Neural Consequences of Sleep Loss on Adolescent Affective FunctionR01DA033064 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FRANZEN, PETER L · 2011 to 2014
$1.2M
EEG SLEEP STUDIES IN RELATION TO AFFECTIVE ILLNESSR37MH024652 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KUPFER, DAVID J · 1991 to 2000
$878k
CBT-I for Bipolar DisorderR34MH080958 · NIMH · UNIVERSITY OF CALIFORNIA BERKELEY · PI HARVEY, ALLISON G · 2009 to 2011
$730k
NCATS NIH HHS UL1 TR000005NCRR NIH HHS UL1 RR024153NHLBI NIH HHS R01 HL112646NIAMS NIH HHS U01 AR052155NIA NIH HHS P01 AG020677NIDA NIH HHS R01 DA033064NIMH NIH HHS R01 MH024652NIMH NIH HHS R01 MH078961NIMH NIH HHS R34 MH080958NIMH NIH HHS R37 MH024652
6 · The paper itself

Abstract

importanceInsomnia is one of the most prevalent health concerns in the population and in clinical practice. Clinicians may be reluctant to address insomnia because of its many potential causes, unfamiliarity with behavioral treatments, and concerns about pharmacologic treatments.

objectiveTo review the assessment, diagnosis, and treatment of insomnia in adults. EVIDENCE REVIEW: Systematic review to identify and summarize previously published quantitative reviews (meta-analyses) of behavioral and pharmacologic treatments for insomnia.

findingsInsomnia is a common clinical condition characterized by difficulty initiating or maintaining sleep, accompanied by symptoms such as irritability or fatigue during wakefulness. The prevalence of insomnia disorder is approximately 10% to 20%, with approximately 50% having a chronic course. Insomnia is a risk factor for impaired function, development of other medical and mental disorders, and increased health care costs. The etiology and pathophysiology of insomnia involve genetic, environmental, behavioral, and physiological factors culminating in hyperarousal. The diagnosis of insomnia is established by a thorough history of sleep behaviors, medical and psychiatric problems, and medications, supplemented by a prospective record of sleep patterns (sleep diary). Quantitative literature reviews (meta-analyses) support the efficacy of behavioral, cognitive, and pharmacologic interventions for insomnia. Brief behavioral interventions and Internet-based cognitive-behavioral therapy both show promise for use in primary care settings. Among pharmacologic interventions, the most evidence exists for benzodiazepine receptor agonist drugs, although persistent concerns focus on their safety relative to modest efficacy. Behavioral treatments should be used whenever possible, and medications should be limited to the lowest necessary dose and shortest necessary duration. CONCLUSIONS AND RELEVANCE: Clinicians should recognize insomnia because of its effects on function and health. A thorough clinical history is often sufficient to identify factors that contribute to insomnia. Behavioral treatments should be used when possible. Hypnotic medications are also efficacious but must be carefully monitored for adverse effects.

Indexed as

Sleep Initiation and Maintenance DisordersCognitive Behavioral TherapyFemaleHumansMiddle AgedRisk Factors

Identifiers

PMID23423416
PMCPMC3632369
OpenAlexW4231896431

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.